{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:58:44Z","timestamp":1779263924836,"version":"3.51.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health & Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental & Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy And Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders And Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006084","name":"National Institutes of Health, Office of AIDS Research","doi-asserted-by":"publisher","award":["UL1-TR000004"],"award-info":[{"award-number":["UL1-TR000004"]}],"id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCSF CTSA","award":["UL1-TR003098"],"award-info":[{"award-number":["UL1-TR003098"]}]},{"name":"JHU ICTR","award":["UL1-TR001881"],"award-info":[{"award-number":["UL1-TR001881"]}]},{"DOI":"10.13039\/100016206","name":"UCLA CTSI","doi-asserted-by":"publisher","award":["P30-AI-050409"],"award-info":[{"award-number":["P30-AI-050409"]}],"id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Atlanta CFAR","award":["P30-AI-073961"],"award-info":[{"award-number":["P30-AI-073961"]}]},{"name":"Miami CFAR","award":["P30-AI-050410"],"award-info":[{"award-number":["P30-AI-050410"]}]},{"DOI":"10.13039\/100011072","name":"UNC CFAR","doi-asserted-by":"publisher","award":["P30-AI-027767"],"award-info":[{"award-number":["P30-AI-027767"]}],"id":[{"id":"10.13039\/100011072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019610","name":"UAB CFAR","doi-asserted-by":"publisher","award":["P30-MH-116867"],"award-info":[{"award-number":["P30-MH-116867"]}],"id":[{"id":"10.13039\/100019610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miami CHARM","award":["UL1-TR001409"],"award-info":[{"award-number":["UL1-TR001409"]}]},{"name":"DC CTSA","award":["KL2-TR001432"],"award-info":[{"award-number":["KL2-TR001432"]}]},{"name":"DC CTSA","award":["TL1-TR001431"],"award-info":[{"award-number":["TL1-TR001431"]}]},{"name":"DC CTSA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To reduce atherosclerotic cardiovascular disease (ASCVD) among US people with human immunodeficiency virus (HIV, PWH), it is critical to assess shortfalls in statin initiation. We aimed to describe patterns in clinically indicated statin initiation among demographically similar people with or at increased vulnerability to HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Multicenter AIDS Cohort Study and Women's Interagency HIV Study, we followed 842 men and 852 women with an indication for statin use based on 2013 American College of Cardiology\/American Heart Association guidelines for statin initiation between January 2014 and March 2020. We estimated 2-year incidence of statin initiation stratified by demographic, clinical, and behavioral characteristics and compared estimates using incidence differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within 2 years of statin indication, 20% of participants reported statin use. Initiation of statin therapy did not differ significantly by HIV status. However, initiation was lower among Black versus non-Black persons, especially among men (14.0% versus 22.3%; difference, \u22128.3%; 95% confidence interval, \u221213.8% to \u22122.8%). Compared with initiation among persons indicated based only on \u22657.5% 10-year predicted ASCVD risk (incidence: men, 14.2%; women, 15.2%), initiation was higher among those with existing ASCVD (incidence: men, 32.9%; women, 22.0%) or diabetes (incidence: men, 26.4%; women, 24.5%). Initiation was lower among current versus noncurrent smokers and higher among those with comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Guideline-driven statin initiation was low, with large inequities by race. With indications for statin use expanding for PWH, redressing barriers to guideline implementation will be crucial to achieving improved outcomes through uptake of these evidence-based therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf207","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:44:58Z","timestamp":1744868698000},"page":"818-826","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-9650","authenticated-orcid":false,"given":"Tiffany L","family":"Breger","sequence":"first","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3069-1650","authenticated-orcid":false,"given":"Daniel J","family":"Westreich","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-0096","authenticated-orcid":false,"given":"Andrew","family":"Edmonds","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-335X","authenticated-orcid":false,"given":"Jessie K","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-0307","authenticated-orcid":false,"given":"Catalina","family":"Ramirez","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia E","family":"Diggs","sequence":"additional","affiliation":[{"name":"UNC Center for AIDS Research, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-1903","authenticated-orcid":false,"given":"Igho","family":"Ofotokun","sequence":"additional","affiliation":[{"name":"School of Medicine, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seble G","family":"Kassaye","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Infectious Diseases, Georgetown University , Washington, DC ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd T","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-8442","authenticated-orcid":false,"given":"Deborah","family":"Konkle-Parker","sequence":"additional","affiliation":[{"name":"Schools of Nursing and Medicine, University of Mississippi Medical Center , Jackson, Mississippi ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Palella","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Northwestern University , Chicago, Illinois ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Krier","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Miami , Miami, Florida ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gypsyamber","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mardge H","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stroger Hospital of Cook County , Chicago, Illinois ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis C","family":"Tien","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California\u2013San Francisco and Department of Veterans Affairs , San Francisco, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-202X","authenticated-orcid":false,"given":"Tonya N","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Medicine, SUNY Downstate Health Sciences University , Brooklyn, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Anastos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine , Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L","family":"Hinderliter","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J","family":"Eron","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-4610","authenticated-orcid":false,"given":"M Bradley","family":"Drummond","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9515-2857","authenticated-orcid":false,"given":"Michelle A","family":"Floris-Moore","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2025110901573388100_ciaf207-B1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B2","doi-asserted-by":"crossref","first-page":"e013744","DOI":"10.1161\/JAHA.119.013744","article-title":"Excess risk for atherosclerotic cardiovascular outcomes among US adults with HIV in the current era","volume":"9","author":"Rosenson","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025110901573388100_ciaf207-B3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with human immunodeficiency virus in the United States","volume":"66","author":"Wong","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025110901573388100_ciaf207-B4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pcad.2020.02.006","article-title":"Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: a narrative review of the literature","volume":"63","author":"Muiruri","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2025110901573388100_ciaf207-B5","first-page":"57","volume-title":"Communities in action: pathways to health equity","author":"National Academies of Sciences, Engineering, and MedicineHealth and Medicine DivisionBoard on Population Health and Public Health PracticeCommittee on Community-Based Solutions to Promote Health Equity in the United States","year":"2017"},{"key":"2025110901573388100_ciaf207-B6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"},{"key":"2025110901573388100_ciaf207-B7","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B8","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"2025110901573388100_ciaf207-B10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists' Collaborators","year":"2012","journal-title":"Lancet"},{"key":"2025110901573388100_ciaf207-B11","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/CIRCULATIONAHA.117.029381","article-title":"High-quality statin trials support the 2013 American College of Cardiology\/American Heart Association cholesterol guidelines after the HOPE-3 trial (Heart Outcomes Prevention Evaluation-3): MESA (the MultiEthnic Study of Atherosclerosis)","volume":"136","author":"Mortensen","year":"2017","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110901573388100_ciaf207-B13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"2025110901573388100_ciaf207-B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B15","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110901573388100_ciaf207-B16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110901573388100_ciaf207-B17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/apc.2017.0145","article-title":"Underutilization of statins when indicated in HIV-seropositive and seronegative women","volume":"31","author":"Todd","year":"2017","journal-title":"AIDS Patient Care STDs"},{"key":"2025110901573388100_ciaf207-B18","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1097\/QAD.0000000000000360","article-title":"2013 American College of Cardiology\/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with\/without subclinical high-risk coronary plaque","volume":"28","author":"Zanni","year":"2014","journal-title":"AIDS"},{"key":"2025110901573388100_ciaf207-B19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/hiv.12794","article-title":"Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients","volume":"21","author":"Blackman","year":"2020","journal-title":"HIV Med"},{"key":"2025110901573388100_ciaf207-B20","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/QAI.0000000000001454","article-title":"Statin prescribing practices in the comprehensive care for HIV-infected patients","volume":"76","author":"Kelly","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025110901573388100_ciaf207-B21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/hiv.13195","article-title":"Statin usage and cardiovascular risk among people living with HIV in the U.S. military HIV natural history study","volume":"23","author":"Larson","year":"2022","journal-title":"HIV Med"},{"key":"2025110901573388100_ciaf207-B22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAI.0000000000003083","article-title":"Statins utilization in adults with HIV: the treatment gap and predictors of statin initiation","volume":"91","author":"Coburn","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025110901573388100_ciaf207-B23","author":"US Department of Health and Human Services (HHS) Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV"},{"key":"2025110901573388100_ciaf207-B24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/aje\/126.2.310","article-title":"The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants","volume":"126","author":"Kaslow","year":"1987","journal-title":"Am J Epidemiol"},{"key":"2025110901573388100_ciaf207-B25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ije\/dyy021","article-title":"Cohort profile: the Women's Interagency HIV Study (WIHS)","volume":"47","author":"Adimora","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2025110901573388100_ciaf207-B26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/aje\/kwab050","article-title":"Characteristics of the MACS\/WIHS combined cohort study: opportunities for research on aging with HIV in the longest US observational study of HIV","volume":"190","author":"D'Souza","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2025110901573388100_ciaf207-B27","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"2025110901573388100_ciaf207-B28","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"2025110901573388100_ciaf207-B29","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B30","author":"National Institute on Alcohol Abuse and Alcoholism"},{"key":"2025110901573388100_ciaf207-B31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ahj.2018.11.012","article-title":"Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons","volume":"209","author":"Riestenberg","year":"2019","journal-title":"Am Heart J"},{"key":"2025110901573388100_ciaf207-B32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/cid\/ciw289","article-title":"Statin utilization and recommendations among HIV- and HCV-infected veterans: a cohort study","volume":"63","author":"Clement","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025110901573388100_ciaf207-B33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11606-008-0891-7","article-title":"The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP\/ATP III criteria for the receipt of lipid lowering medication","volume":"24","author":"Freiberg","year":"2009","journal-title":"J Gen Intern Med"},{"key":"2025110901573388100_ciaf207-B34","doi-asserted-by":"crossref","first-page":"e007107","DOI":"10.1161\/JAHA.117.007107","article-title":"Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study","volume":"6","author":"Ladapo","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025110901573388100_ciaf207-B35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0897190021999790","article-title":"Patients living with HIV are less likely to receive appropriate statin therapy for cardiovascular disease risk reduction","volume":"35","author":"Emmons","year":"2022","journal-title":"J Pharm Pract"},{"key":"2025110901573388100_ciaf207-B36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2022.03.006","article-title":"Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease","volume":"249","author":"Erqou","year":"2022","journal-title":"Am Heart J"},{"key":"2025110901573388100_ciaf207-B37","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/ajhp\/zxac224","article-title":"Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease","volume":"79","author":"Gallegos Aragon","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"2025110901573388100_ciaf207-B38","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/aje\/kwv001","article-title":"Risk","volume":"181","author":"Cole","year":"2015","journal-title":"Am J Epidemiol"},{"key":"2025110901573388100_ciaf207-B40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacl.2015.11.002","article-title":"Provider understanding of the 2013 ACC\/AHA cholesterol guideline","volume":"10","author":"Virani","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2025110901573388100_ciaf207-B41","first-page":"2048004020947298","article-title":"Examination of physicians' adherence to the 2013 ACC\/AHA statin\/cholesterol guidelines using a framework of awareness to adherence: a cross-sectional study","volume":"9","author":"Fleming","year":"2020","journal-title":"JRSM Cardiovasc Dis"},{"key":"2025110901573388100_ciaf207-B42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12875-021-01563-0","article-title":"Factors affecting statin uptake among people living with HIV: primary care provider perspectives","volume":"22","author":"Ober","year":"2021","journal-title":"BMC Fam Pract"},{"key":"2025110901573388100_ciaf207-B43","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2025110901573388100_ciaf207-B44","doi-asserted-by":"crossref","first-page":"102175","DOI":"10.1016\/j.pmedr.2023.102175","article-title":"Effect of 2018 American College of Cardiology\/American Heart Association guideline change on statin prescription for people living with HIV","volume":"33","author":"Pan","year":"2023","journal-title":"Prev Med Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf207\/62950398\/ciaf207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/818\/62950398\/ciaf207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/818\/62950398\/ciaf207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:57:47Z","timestamp":1762671467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/4\/818\/8115644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf207","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,4,17]]}}}